Targeted Multiplexed MALDI MS Platform Enables Detection of Novel Pathogenic Forms of Tau, Amyloid Beta and Alpha Synuclein
Vladislav Bergo · 2025
Read Targeted Multiplexed MALDI MS Platform Enables Detection of Novel Pathogenic Forms of Tau, Amyloid Beta and Alpha Synuclein by Vladislav Bergo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715303.txt.
Description
Vladislav Bergo presents, in a 2025 paper, a mass spectrometry platform built to catch the many chopped and altered forms of three proteins tied to brain disease. New Alzheimer's drugs aim at tau, amyloid beta, and alpha synuclein, but standard tests see only a few forms of each. Trials need finer fingerprints to match patients to treatments. The platform fishes target fragments from spinal fluid with antibody-coated beads, then weighs them precisely.
It detected more than forty amyloid fragments, including several truncation patterns never reported before. Key plaque markers were measured with tight precision. Patterns differed clearly between healthy and Alzheimer's samples, suggesting distinct protein processing. Probes for tau also exposed heavy natural cutting of the protein. The author offers the method as a companion testing base for personalized dementia medicine.
Catalog record
| CREATOR | Vladislav Bergo |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |